EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti‐angiogenic Therapy in Armored and Cold Tumors

Jie Mei, Kai Yang, Xinkang Zhang, Zhiwen Luo, Min Tian, Hanfang Fan, Jiahui Chu, Yan Zhang, Junli Ding, Junying Xu iD, Yun Cai, Yongmei Yin

Advanced Science · 2025

DOI: 10.1002/advs.202409147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jie Mei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 211166, P. R. China. Hauptthemen laut MEDLINE: Neovascularization, Pathologic, Angiogenesis Inhibitors, Collagen, Lung Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, High-level Innovation Team of Nanjing Medical University, Beijing Xisike Clinical Oncology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A previous study classifies solid tumors based on collagen deposition and immune infiltration abundance, identifying a refractory subtype termed armored & cold tumors, characterized by elevated collagen deposition and diminished immune infiltration. Beyond its impact on immune infiltration, collagen deposition also influences tumor angiogenesis. This study systematically analyzes the association between immuno‐collagenic subtypes and angiogenesis across diverse cancer types. As a result, armored & cold tumors exhibit the highest angiogenic activity in lung adenocarcinoma (LUAD). Single‐cell and spatial transcriptomics reveal close interactions and spatial co‐localization of fibroblasts and endothelial cells. In vitro experiments demonstrate that collagen stimulates tumor cells to express vascular endothelial growth factor A (VEGFA) and directly enhances vessel formation and endothelial cell proliferation through sex determining region Y box 18 (SOX18) upregulation. Collagen inhibition via multiple approaches effectively suppresses tumor angiogenesis in vivo. In addition, armored & cold tumors display superior responsiveness to anti‐angiogenic therapy in advanced LUAD cohorts. Post‐immunotherapy resistance, the transformation into armored & cold tumors emerges as a potential biomarker for selecting anti‐angiogenic therapy. In summary, collagen deposition is shown to drive angiogenesis across various cancers, providing a novel and actionable framework to refine therapeutic strategies combining chemotherapy with anti‐angiogenic treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neovascularization, PathologicAngiogenesis InhibitorsCollagenLung NeoplasmsAdenocarcinoma of LungHumansAnimalsMiceVascular Endothelial Growth Factor ACell Line, TumorAngiogenesis

Stichwörter der Autor:innen

anti‐angiogenic therapyarmored & cold tumorcollagen depositionvascularization

Substanzen

Angiogenesis InhibitorsCollagenVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 211166, P. R. China.
  • The First Clinical Medicine College, Nanjing Medical University, Nanjing, Jiangsu, 211166, P. R. China.
  • Department of Sports Medicine, Huashan Hospital Affiliated to Fudan University, Shanghai, 200040, P. R. China.
  • Departments of Oncology, Wuxi People's Hospital, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, P. R. China.
  • Departments of Gynecology, The Women's Hospital Affiliated to Jiangnan University, Wuxi, 214023, China.
  • Central Laboratory, Changzhou Jintan First People's Hospital, The Affiliated Jintan Hospital of Jiangsu University, Changzhou, Jiangsu, 213200, P. R. China.

ORCID-Profile: Junying Xu

Förderung

  • National Natural Science Foundation of China
  • High-level Innovation Team of Nanjing Medical University
  • Beijing Xisike Clinical Oncology Research Foundation
  • Hengrui Pharmaceutical Clinical Research Fund of Personalized Medical Collaborative Innovation Center
  • Construction Fund for Provincial Key Clinical specialty of Wuxi People's Hospital

Zitieren

APA

Mei, J., Yang, K., Zhang, X., Luo, Z., Tian, M., Fan, H., Chu, J., Zhang, Y., Ding, J., Xu, J., Cai, Y., & Yin, Y. (2025). Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti‐angiogenic Therapy in Armored and Cold Tumors. Advanced Science. https://doi.org/10.1002/advs.202409147

Vancouver

Mei J, Yang K, Zhang X, Luo Z, Tian M, Fan H, et al. Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti‐angiogenic Therapy in Armored and Cold Tumors. Advanced Science. 2025. doi:10.1002/advs.202409147

BibTeX
@article{Mei2025,
  author = {Mei, Jie and Yang, Kai and Zhang, Xinkang and Luo, Zhiwen and Tian, Min and Fan, Hanfang and Chu, Jiahui and Zhang, Yan and Ding, Junli and Xu, Junying and Cai, Yun and Yin, Yongmei},
  title = {Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti‐angiogenic Therapy in Armored and Cold Tumors},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202409147}
}
Kostenlos starten →